The most recent trading session ended with Novavax (NVAX) standing at $12.91, reflecting a +1.77% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.21% for the day. On the other hand, the Dow registered a loss of 0.14%, and the technology-centric Nasdaq decreased by 0.05%. Shares of the vaccine maker witnessed a gain of 3.17% over the previous month, beating the performance of the Medical sector with its loss of 3.28% and underperforming the S&P 500 ...